Erin Burkhart sold $106k of BMRN
GVP, Chief Accounting Officer at BIOMARIN PHARMACEUTICAL INC. 1,786 shares at an average of $59.31, traded May 20, 2025, filed May 20, 2025.
Score components
- +15RoleOfficer
- +10Trade size$106k at market
- +5Share of holdings soldSold 11% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.8%, 3m -4.4%, 6m -9.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001048477-25-000060, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 19, 2025 | FTax withholding Common Stock10b5-1 | -996 | $59.27 | $59k | 15,959 | May 20, 2025 |
| May 20, 2025 | SOpen-market sale Common Stock10b5-1 | -1,786 | $59.31 | $106k | 14,173 | May 20, 2025 |
Related signals
Other insiders at BIOMARIN PHARMACEUTICAL INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | BMRNsell BIOMARIN PHARMACEUTICAL INC | George Eric Davis EVP, Chief Legal Officer | $1.2M 17,557 shares | -22% | |
| 27Weak | BMRNsell BIOMARIN PHARMACEUTICAL INC | Gregory R Friberg EVP, Chief R&D Officer | $177k 3,281 shares | -6% | |
| 60Notable | BIOMARIN PHARMACEUTICAL INC | Charles Greg Guyer EVP, Chief Technical Officer | $997k 16,486 shares | -17% | |
| 65Notable | BIOMARIN PHARMACEUTICAL INC | George Eric Davis EVP, Chief Legal Officer | $1.6M 26,061 shares | -26% | |
| 51Moderate | BIOMARIN PHARMACEUTICAL INC | Gregory R Friberg EVP, Chief R&D Officer | $382k 6,326 shares | -14% | |
| 0Weak | BIOMARIN PHARMACEUTICAL INC | Cristin Hubbard EVP, Chief Commercial Officer | $18k 273 shares | -1% | |
| 13Weak | BIOMARIN PHARMACEUTICAL INC | Erin Burkhart GVP, Chief Accounting Officer | $93k 1,295 shares | -7% | |
| 41Moderate | BIOMARIN PHARMACEUTICAL INC | Charles Greg Guyer EVP, Chief Technical Officer | $501k 7,034 shares | -7% | |
| 12Weak | BIOMARIN PHARMACEUTICAL INC | Erin Burkhart GVP, Chief Accounting Officer | $92k 1,344 shares | -9% | |
| 30Weak | BMRNsell BIOMARIN PHARMACEUTICAL INC | Charles Greg Guyer EVP, Chief Technical Officer | $350k 5,278 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.